BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin B, Huang F, Liang Y, Yang Z, Zhong R. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28:543-550. [PMID: 23173724 DOI: 10.1111/jgh.12040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Rodrigues PM, Perugorria MJ, Santos-laso A, Bujanda L, Beuers U, Banales JM. Primary biliary cholangitis: A tale of epigenetically-induced secretory failure? Journal of Hepatology 2018;69:1371-83. [DOI: 10.1016/j.jhep.2018.08.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
2 O'Hara SP, Gradilone SA, Masyuk TV, Tabibian JH, LaRusso NF. MicroRNAs in Cholangiopathies. Curr Pathobiol Rep 2014;2:133-42. [PMID: 25097819 DOI: 10.1007/s40139-014-0048-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
3 Xie Y, Ma H, Lian Z. Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity. Clinic Rev Allerg Immunol 2016;50:390-403. [DOI: 10.1007/s12016-015-8502-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
4 Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10:542-552. [PMID: 23689081 DOI: 10.1038/nrgastro.2013.87] [Cited by in Crossref: 409] [Cited by in F6Publishing: 382] [Article Influence: 45.4] [Reference Citation Analysis]
5 Li Y, Tang R, Ma X. Epigenetics of Primary Biliary Cholangitis. Adv Exp Med Biol 2020;1253:259-83. [PMID: 32445099 DOI: 10.1007/978-981-15-3449-2_10] [Reference Citation Analysis]
6 Pisarello MJ, Loarca L, Ivanics T, Morton L, LaRusso N. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment. J Clin Med 2015;4:1688-712. [PMID: 26343736 DOI: 10.3390/jcm4091688] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
7 Takahashi P, Xavier DJ, Evangelista AF, Manoel-Caetano FS, Macedo C, Collares CV, Foss-Freitas MC, Foss MC, Rassi DM, Donadi EA, Passos GA, Sakamoto-Hojo ET. MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus. Gene 2014;539:213-23. [PMID: 24530307 DOI: 10.1016/j.gene.2014.01.075] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
8 Tan Y, Pan T, Ye Y, Ge G, Chen L, Wen D, Zou S. Serum microRNAs as potential biomarkers of primary biliary cirrhosis. PLoS One. 2014;9:e111424. [PMID: 25347847 DOI: 10.1371/journal.pone.0111424] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
9 Tian Y, Liu J, Bai X, Tan X, Cao Y, Qin K, Zhao Z, Zhang Y. MicroRNA expression profile of surgical removed mandibular bone tissues from patients with mandibular prognathism. Journal of Surgical Research 2015;198:127-34. [DOI: 10.1016/j.jss.2015.04.071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
10 Wang X, Wen X, Zhou J, Qi Y, Wu R, Wang Y, Kui Y, Hua R, Jin Q. MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients. PLoS One 2017;12:e0184292. [PMID: 28886078 DOI: 10.1371/journal.pone.0184292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Olaizola P, Lee-law P, Arbelaiz A, Lapitz A, Perugorria M, Bujanda L, Banales J. MicroRNAs and extracellular vesicles in cholangiopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:1293-307. [DOI: 10.1016/j.bbadis.2017.06.026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
12 Roberto R, Laura C, Atsushi T, Pietro I. Geoepidemiology and (epi-)genetics in primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 2018;34-35:11-5. [DOI: 10.1016/j.bpg.2018.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Katsushima F, Takahashi A, Sakamoto N, Kanno Y, Abe K, Ohira H. Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatol Res. 2013; Jul 9. [Epub ahead of print]. [PMID: 23834361 DOI: 10.1111/hepr.12198] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
14 Arvaniti P, Zachou K, Lyberopoulou A, Gatselis NK, Brooks WH, Dalekos GN, Renaudineau Y. Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis. Epigenomes 2019;3:15. [PMID: 34968227 DOI: 10.3390/epigenomes3030015] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Tanaka A, Leung PS, Gershwin ME. The Genetics and Epigenetics of Primary Biliary Cholangitis. Clinics in Liver Disease 2018;22:443-55. [DOI: 10.1016/j.cld.2018.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
16 Qin B, Wei T, Wang L, Ma N, Tang Q, Liang Y, Yang Z, Zhou L, Zhong R. Decreased expression of TIPE2 contributes to the hyperreactivity of monocyte to Toll-like receptor ligands in primary biliary cirrhosis: TIPE2 role in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology 2016;31:1177-83. [DOI: 10.1111/jgh.13251] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
17 Han Y, Glaser S, Meng F, Francis H, Marzioni M, McDaniel K, Alvaro D, Venter J, Carpino G, Onori P, Gaudio E, Alpini G, Franchitto A. Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood) 2013;238:549-65. [PMID: 23856906 DOI: 10.1177/1535370213489926] [Cited by in Crossref: 45] [Cited by in F6Publishing: 91] [Article Influence: 5.0] [Reference Citation Analysis]
18 Liu Q, Li Y, Ma X, Tang R. Epigenetics of autoimmune liver diseases: current progress and future directions. Journal of Bio-X Research 2019;2:46-55. [DOI: 10.1097/jbr.0000000000000030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Itoh A, Adams D, Huang W, Wu Y, Kachapati K, Bednar KJ, Leung PSC, Zhang W, Flavell RA, Gershwin ME, Ridgway WM. Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis. Hepatology 2021;74:835-46. [PMID: 33462854 DOI: 10.1002/hep.31724] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Shi J, Chi S, Xue J, Yang J, Li F, Liu X. Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases. J Immunol Res. 2016;2016:9392132. [PMID: 27110577 DOI: 10.1155/2016/9392132] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 8.2] [Reference Citation Analysis]
21 Migita K, Komori A, Kozuru H, Jiuchi Y, Nakamura M, Yasunami M, Furukawa H, Abiru S, Yamasaki K, Nagaoka S, Hashimoto S, Bekki S, Kamitsukasa H, Nakamura Y, Ohta H, Shimada M, Takahashi H, Mita E, Hijioka T, Yamashita H, Kouno H, Nakamuta M, Ario K, Muro T, Sakai H, Sugi K, Nishimura H, Yoshizawa K, Sato T, Naganuma A, Komatsu T, Oohara Y, Makita F, Tomizawa M, Yatsuhashi H. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis. PLoS One. 2015;10:e0136908. [PMID: 26575387 DOI: 10.1371/journal.pone.0136908] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
22 Tanaka A, Leung PS, Gershwin ME. Evolution of our understanding of PBC. Best Practice & Research Clinical Gastroenterology 2018;34-35:3-9. [DOI: 10.1016/j.bpg.2018.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
23 Erice O, Munoz-Garrido P, Vaquero J, Perugorria MJ, Fernandez-Barrena MG, Saez E, Santos-Laso A, Arbelaiz A, Jimenez-Agüero R, Fernandez-Irigoyen J, Santamaria E, Torrano V, Carracedo A, Ananthanarayanan M, Marzioni M, Prieto J, Beuers U, Oude Elferink RP, LaRusso NF, Bujanda L, Marin JJG, Banales JM. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation. Hepatology 2018;67:1420-40. [PMID: 28922472 DOI: 10.1002/hep.29533] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
24 Huang C, Xing X, Xiang X, Fan X, Men R, Ye T, Yang L. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets. Biomed Pharmacother 2020;130:110558. [PMID: 32781357 DOI: 10.1016/j.biopha.2020.110558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Esparza-baquer A, Labiano I, Bujanda L, Perugorria MJ, Banales JM. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools. Clinics and Research in Hepatology and Gastroenterology 2016;40:15-27. [DOI: 10.1016/j.clinre.2015.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
26 Long H, Yin H, Wang L, Gershwin ME, Lu Q. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. J Autoimmun 2016;74:118-38. [PMID: 27396525 DOI: 10.1016/j.jaut.2016.06.020] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 16.8] [Reference Citation Analysis]
27 Han Y, Glaser S, Meng F, Francis H, Marzioni M, McDaniel K, Alvaro D, Venter J, Carpino G, Onori P, Gaudio E, Alpini G, Franchitto A. Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood). 2013;238:549-565. [PMID: 23856906 DOI: 10.1177/1535370213489926.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Gerussi A, Paraboschi EM, Cappadona C, Caime C, Binatti E, Cristoferi L, Asselta R, Invernizzi P. The Role of Epigenetics in Primary Biliary Cholangitis. Int J Mol Sci 2022;23:4873. [PMID: 35563266 DOI: 10.3390/ijms23094873] [Reference Citation Analysis]
29 Kouroumalis E, Samonakis D, Voumvouraki A. Biomarkers for primary biliary cholangitis: current perspectives. Hepat Med 2018;10:43-53. [PMID: 29950909 DOI: 10.2147/HMER.S135337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Huang YQ. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World J Hepatol 2016; 8(33): 1419-1441 [PMID: 27957241 DOI: 10.4254/wjh.v8.i33.1419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
31 Marin JJ, Bujanda L, Banales JM. MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol. 2014;30:303-309. [PMID: 24553410 DOI: 10.1097/MOG.0000000000000051] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]